AUTONOMIX MEDICAL, INC. Cash and Restricted Cash
AUTONOMIX MEDICAL, INC. (AMIX) had Cash and Restricted Cash of $1.22 million as of 2023-12-31, per its 10-Q filed 2024-02-13.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2024-02-13
- 2023-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.22M.
- 2023-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $865.00K.
- 2022-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $810.00K.
- 2022-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.04M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2023-12-31 | $1.22M 10-Q · filed 2024-02-13 |
| 2023-03-31 | $865.00K 10-Q · filed 2024-02-13 |
| 2022-12-31 | $810.00K 10-Q · filed 2024-02-13 |
| 2022-03-31 | $2.04M 10-Q · filed 2024-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |